Skip to content

Abbott ABT Investment Purchases

Investment Purchases at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$226.1M+47.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$144M-42.6%
Haemonetics logo
HaemoneticsHAE
$0-100%
DexCom logo
DexComDXCM
$688.6M+48.9%
Edwards Lifesciences logo
Edwards LifesciencesEW
$641.1M+1.0%
Medtronic logo
MedtronicMDT
$2.15B+0.9%

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$158.05B-32.0%
Enterprise value$185.3B-22.5%
P/E25.2×+8.5×
P/S3.5×-1.9×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Abbott’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's investment purchases?
Abbott (ABT) reported investment purchases of $41.75M in Q4 2025.
How has Abbott's investment purchases changed year-over-year?
Abbott's investment purchases decreased by 1.2% year-over-year, from $42.25M to $41.75M.
What is the long-term trend for Abbott's investment purchases?
Over 4 years (2021 to 2025), Abbott's investment purchases has grown at a -0.9% compound annual growth rate (CAGR), from $173M to $167M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.